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The impedance threshold device (ITD) is designed to enhance venous return and
cardiac output during cardiopulmonary resuscitation (CPR) by increasing the degree
of negative intrathoracic pressure. Previous studies have suggested that the use of an
ITD during CPR may improve survival rates after cardiac arrest.
Methods

We compared the use of an active ITD with that of a sham ITD in patients with out-ofhospital cardiac arrest who underwent standard CPR at 10 sites in the United States
and Canada. Patients, investigators, study coordinators, and all care providers were
unaware of the treatment assignments. The primary outcome was survival to hospital discharge with satisfactory function (i.e., a score of ≤3 on the modified Rankin
scale, which ranges from 0 to 6, with higher scores indicating greater disability).
Results

Of 8718 patients included in the analysis, 4345 were randomly assigned to treatment
with a sham ITD and 4373 to treatment with an active device. A total of 260 patients
(6.0%) in the sham-ITD group and 254 patients (5.8%) in the active-ITD group met
the primary outcome (risk difference adjusted for sequential monitoring, −0.1 percentage points; 95% confidence interval, −1.1 to 0.8; P = 0.71). There were also no
significant differences in the secondary outcomes, including rates of return of spontaneous circulation on arrival at the emergency department, survival to hospital
admission, and survival to hospital discharge.
Conclusions

Use of the ITD did not significantly improve survival with satisfactory function among
patients with out-of-hospital cardiac arrest receiving standard CPR. (Funded by the
National Heart, Lung, and Blood Institute and others; ROC PRIMED ClinicalTrials.gov
number, NCT00394706.)
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S

tandard cardiopulmonary resuscitation (CPR), defined as manual chest compressions with rescue breathing, can be lifesaving but provides only a relatively small fraction
of normal cardiac output, even when performed
correctly.1,2 One proposed strategy to augment cardiac output during CPR is the use of an impedance
threshold device (ITD).3-5
The ITD is designed to enhance venous return
and cardiac output during CPR by increasing the
degree of negative intrathoracic pressure (Fig. 1 in
the Supplementary Appendix, available with the
full text of this article at NEJM.org). This effect is
achieved by preventing the passive inflow of air
into the chest during chest recoil between chest
compressions without impeding active ventilation.
The ITD has been found to improve hemodynamics, the perfusion of vital organs, and neurologically intact survival in studies in animals.3-5 The
results of small, short-term clinical trials have suggested that the ITD can increase systolic blood
pressure during resuscitation and improve shortterm survival rates.6-8 The 2005 American Heart
Association guidelines gave a class IIa recommendation for use of the ITD to improve hemodynamic variables and the return of spontaneous
circulation, although increased long-term survival
rates had not been documented.9 We therefore
conducted a large, randomized trial to test whether standard CPR with the use of an active ITD, as
compared with standard CPR with the use of a
sham ITD, improves rates of hospital discharge
with satisfactory function for adults with out-ofhospital cardiac arrest.

Me thods
Study Setting and Design

We carried out a randomized comparison of the use
of an active ITD with that of a sham ITD during
standard CPR. This investigation was designed, reviewed, and implemented by the Resuscitation Outcomes Consortium (ROC) and was conducted concurrently with a companion study of early rhythm
analysis versus later rhythm analysis, reported by
Stiell et al. elsewhere in this issue of the Journal.10
Most patients were enrolled simultaneously in both
components of the ROC Prehospital Resuscitation
Impedance Valve and Early Versus Delayed Analysis (ROC PRIMED) trial: the active-ITD-versussham-ITD component and the early-analysis-versuslater-analysis component, although the eligibility

n engl j med 365;9

criteria for the two components were slightly different. Details of the trial design and the relationship between the two studies can be found in the
article by Stiell et al.,10 in a previously published
description of the trial methods,11 and in the Supplementary Appendix.
The trial was supported by the National Heart,
Lung, and Blood Institute; the National Institute of
Neurological Disorders and Stroke; the Canadian
Institutes of Health Research; and the Heart and
Stroke Foundation of Canada. The manufacturer
of the ITD, Advanced Circulatory Systems, supplied devices to the study network at a reduced
price for the trial and provided nonbinding advice
to the investigators about the design of the study
before it was implemented. The authors vouch for
the completeness and accuracy of the data and of
all analyses and for the fidelity of the study to the
trial protocol (available at NEJM.org).
Patient Population

All adults with nontraumatic, out-of-hospital cardiac arrest were eligible for enrollment if they were
being treated with resuscitative efforts by emergency medical services (EMS) personnel who were participating in the ROC. Patients were excluded if they
were incarcerated, were known to be pregnant, had
do-not-attempt-resuscitation orders, had arrest due
to exsanguinations or severe burns, had an existing
tracheostomy, or were undergoing attempted resuscitation with the use of other mechanical CPR devices. This study qualified for exception from informed consent required for emergency research
according to the U.S. Food and Drug Administration and Canadian Tri-Council Agreement regulations. The protocol was approved by local institutional review and research ethics boards.
Treatment Assignments

Patients were randomly assigned to undergo CPR
that included either an active ITD or an identicalappearing sham ITD. Each device was packaged in
a sealed plastic bag and identified for analysis as
sham or active by means of a numerical code
known only to the data coordinating center. Study
devices were assigned randomly in a 1:1 ratio on the
basis of permuted blocks of concealed size within
strata defined by the participating geographic site
and further defined within the site by the participating EMS agency or subagency. EMS personnel
were instructed to use the devices in the assigned,
sequential order. Patients, investigators, study co-
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ordinators, and all persons caring for the patient
were unaware of the treatment assignments. Patients were considered to be enrolled in the study
once an ITD package was opened.
Intervention

The first EMS responders to arrive at the scene of
the arrest who were equipped with a randomly assigned ITD (active or sham) attached the device between the ventilation bag and face mask or between
the bag and an advanced airway (e.g., Combitube
[Tyco Healthcare Group], laryngeal mask airway, or
endotracheal tube) (Fig. 1 in the Supplementary
Appendix). Responders were encouraged to implement use of the device within 5 minutes after their
arrival or as soon as clinically possible. Standard
CPR in most agencies was provided with a 30:2 ratio of chest compressions to ventilations. Several
agencies used continuous compressions with interposed ventilations at a ratio of 10:1.
To avoid impeding inspiration in patients whose
spontaneous breathing was unrecognized, EMS
providers were instructed to remove the ITD immediately on the return of spontaneous circulation
but to reapply it for recurrent cardiac arrest. If
the device filled with fluid, it was removed and
cleared, the patient’s airway was suctioned, and the
device was reapplied. If the device again filled with
fluid, its use was permanently discontinued. Use of
the ITD was terminated on arrival at the hospital.
Study Outcomes

The primary outcome was survival to hospital discharge with satisfactory functional status, defined
as a score of 3 or less on the modified Rankin
scale, a validated scale ranging from 0 to 6 that is
commonly used for measuring the performance of
daily activities by people who have had a stroke.
Lower scores indicate better performance; scores
of 4 or higher indicate severe disability or death.
Data used to determine the score on the Rankin
scale were abstracted from the clinical record.12
Secondary outcomes included return of spontaneous circulation on arrival at the emergency
department, survival to hospital admission, and
survival to hospital discharge. Adverse events were
recorded by the responders and other clinicians
involved in the care of the patients on the basis of
EMS records, hospital charts, and autopsy reports
and were monitored by an independent data and
safety monitoring board.
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Training of EMS Personnel

EMS personnel were trained in ITD function, proper use of the ITD, and all aspects of protocol implementation, with an emphasis on the optimal performance of CPR according to local guidelines.13
The trial included a run-in phase; EMS personnel
were required to provide evidence of acceptable
performance to an internal monitoring committee
before they were permitted to participate in the
main trial. Retraining occurred at periodic intervals throughout the trial, and the committee monitored CPR performance and compliance with the
protocol.
Statistical Analysis

We estimated that a sample of 14,154 patients in
the analysis population (7077 per study group)
would be needed to achieve 90% power to detect
a 25% relative improvement in the primary outcome with the use of the active ITD as compared
with the sham ITD (6.7% vs. 5.3%).11 The data and
safety monitoring board monitored trial progress
and safety and used formal stopping boundaries.
Adverse events classified as possibly related to
ITD use (ITD not removed by rescuer after the return of spontaneous circulation, suspected device
failure, pulmonary edema, and airway bleeding)
were monitored in all patients who had an active
or sham ITD applied either during the run-in phase
or in the main trial (defined as the safety population). The intention-to-treat population included all
patients for whom an ITD package was opened
during the main trial. The primary effectiveness
analysis was performed in a modified intention-totreat population, which included all patients who
had an ITD (active or sham) applied during the
main trial but excluded those who had cardiac
arrest due to hanging, drowning, electrocution,
or strangulation or for whom the response time
exceeded 15 minutes.11
For the primary analysis, we used a z statistic
to compare the rates of survival to hospital discharge with satisfactory functional status in the
two groups. To adjust for group sequential monitoring, the point estimate was bias-adjusted,14 and
confidence intervals and P values were calculated
from the maximum likelihood–based ordering of
the outcome.15 Between-group differences in the
rates of survival to discharge with satisfactory
functional status, adjusted for baseline characteristics, were estimated with the use of a multiple
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Table 1. Characteristics before Randomization in the Modified Intention-to-Treat Population.*
Characteristic

Sham ITD (N = 4345)

Age — yr†
Male sex — no. of patients/total no. (%)

Active ITD (N = 4373)

Not Enrolled (N = 3613)

66.6±16.5

67.2±16.4

66.0±17.2

2790/4345 (64.2)

2838/4372 (64.9)

2086/3281 (63.6)

Obvious cause of arrest — no. of patients/total no. (%)‡

128/4345 (2.9)

91/4373 (2.1)

197/3279 (6.0)

Public location — no. of patients/total no. (%)

621/4345 (14.3)

609/4373 (13.9)

544/3281 (16.6)

Witness status — no. of patients/total no. (%)
EMS witnessed

331/4345 (7.6)

367/4373 (8.4)

624/3281 (19.0)

1794/4345 (41.3)

1754/4373 (40.1)

1118/3281 (34.1)

Yes

1681/4345 (38.7)

1672/4373 (38.2)

1039/3281 (31.7)

No

2133/3281 (65.0)

Bystander witnessed
Bystander performed CPR — no. of patients/total no. (%)

2440/4345 (56.2)

2474/4373 (56.6)

Time from dispatch to first EMS arrival — min

5.8±2.2

5.8±2.3

6.6±4.6§

Time from dispatch to first EMS arrival ≤4 min
— no. of patients/total no. (%)

913/4345 (21.0)

887/4373 (20.3)

541/3573 (15.1)

9.0±4.9

9.0±4.9

10.3±7.3

4261/4345 (98.1)

4293/4373 (98.2)

3343/3613 (92.5)

168 (3.9)

189 (4.3)

120 (3.3)

Time from dispatch to first arrival of ALS providers
— min¶
Treated by ALS providers — no. of patients/total no. (%)
Site — no. of patients (%)
A
B

373 (8.6)

373 (8.5)

611 (16.9)

C

387 (8.9)

371 (8.5)

102 (2.8)

D

1355 (31.2)

1362 (31.1)

1530 (42.3)

E

165 (3.8)

153 (3.5)

125 (3.5)

F

132 (3.0)

139 (3.2)

81 (2.2)

G

978 (22.5)

977 (22.3)

319 (8.8)

H

667 (15.4)

686 (15.7)

598 (16.6)

I

29 (0.7)

30 (0.7)

72 (2.0)

J

91 (2.1)

93 (2.1)

55 (1.5)

* Plus–minus values are means ±SD. The P values for all comparisons were not significant (≥0.05) unless otherwise stated. ALS denotes advanced
life support, EMS emergency medical services, and ITD impedance threshold device.
† The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 4337, 4365, and 3264, respectively.
‡ Obvious causes of arrest included but were not limited to drug poisoning, foreign-body obstruction, terminal illness, and respiratory compromise.
The difference between sham-ITD and active-ITD groups was significant (P<0.05).
§ The total number of patients in the not-enrolled group was 3573.
¶ The comparison with respect to the time from dispatch to first arrival of advanced life support was based only on the cases for which advanced life
support was on the scene and the elapsed time was known (4259, 4291, and 3338 in the sham-ITD, active-ITD, and not-enrolled groups, respectively).

linear regression model with bootstrap standard
errors to allow for the binary nature of the outcome. Mean scores on the modified Rankin scale
were compared between study groups with the use
of a two-sample t-test with unequal variances. All
reported P values are based on two-sided tests; a
P value of less than 0.05 was considered to indicate statistical significance. Heterogeneity of the
treatment effect across sites was assessed by
means of the weighted least-squares chi-square
statistic with 9 degrees of freedom.16

n engl j med 365;9

R e sult s
Study Participants

The first EMS system entered the run-in phase in
June 2007. All 10 sites halted enrollment in November 2009, when the data and safety monitoring board recommended termination because
interim analysis showed that the findings were
not likely to change with continuation of the
study. Of the 13,924 patients with cardiac arrest
who were screened, 12,863 potentially eligible
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patients were identified; 9220 patients (71.7% of
those eligible) were randomly assigned to either
the sham ITD (4601) or the active ITD (4619). On
the basis of a priori exclusion criteria,11 the primary outcome was subsequently assessed for
4345 participants in the sham-ITD group and
4373 participants in the active-ITD group (Fig. 2
in the Supplementary Appendix). Differences in
prerandomization and postrandomization characteristics of the patients, as well as characteristics
of EMS and hospital treatments, were not considered to be clinically significant. Prerandomiza-

m e dic i n e

of

tion and postrandomization characteristics of the
3613 patients who were eligible but not enrolled in
the trial are also reported and differed with respect
to several of the characteristics (Tables 1 and 2).
Outcomes

A total of 260 of the 4345 patients (6.0%) in the
sham-ITD group and 254 of the 4373 patients
(5.8%) in the active-ITD group survived to hospital
discharge with a modified Rankin scale score of
3 or less (risk difference adjusted for sequential
monitoring, −0.1 percentage points; 95% confi-

Table 2. Patient Characteristics and Treatments Received after Randomization in the Modified Intention-to-Treat Population.*
Characteristic

Sham ITD (N = 4345)

Active ITD (N = 4373)

4.0 (2.4–6.4)

4.0 (2.4–6.5)

2589/4114 (62.9)

2539/4127 (61.5)

Not Enrolled (N = 3613)

Time from arrival of ITD-equipped EMS personnel to ITD
application
Median (interquartile range) — min
Interquartile range
≤5 min — no. of patients (%)
First rhythm interpretation — no. of patients (%)
Shockable VT or VF

1096 (25.2)

1040 (23.8)

763 (21.1)

Pulseless electrical activity

1007 (23.2)

1080 (24.7)

703 (19.5)

Asystole

1946 (44.8)

1903 (43.5)

1228 (34.0)

273 (6.3)

327 (7.5)

473 (13.1)

AED used, no shock advised, and no recording available
Perfusing rhythm after initial CPR

6 (0.1)

5 (0.1)

7 (0.2)

17 (0.4)

18 (0.4)

439 (12.2)

1791/4344 (41.2)

1733/4368 (39.7)

1159/3270 (35.4)

3.3±2.8

3.3±2.8

2.7±2.5

Attempted

3620 (83.3)

3644 (83.3)

2047/3281 (62.4)

Successful

3312 (76.2)

3332 (76.2)

1738/3281 (53.0)

16.7±11.7

17.3±12.1

16.8±11.5

8.1±8.0

8.0±7.6

11.2±25.5

Unknown or could not be determined
Shocks applied
No. of patients/total no. (%)
No. of shocks, if given†
Prehospital intubation — no. of patients (%)

CPR process measures up to 5 min or until intubation
Pause before shock — sec‡
Pause after shock — sec§

107.4±19.2

107.3±18.1

109.3±21.7

Compression depth — mm‖

Compression rate — no./min¶

42.4±12.0

42.8±12.2

41.3±11.9

CPR fraction**

0.69±0.2

0.69±0.2

0.67 (0.2)

Drugs administered before arrival at hospital — no. of
patients/total no. (%)

802

Epinephrine††

3791/4336 (87.4)

3856/4361 (88.4)

2044/3244 (63.0)

Sodium bicarbonate

1033/4336 (23.8)

1066/4360 (24.4)

339/3244 (10.5)

Atropine

3009/4336 (69.4)

3077/4360 (70.6)

1721/3244 (53.1)

Lidocaine

597/4336 (13.8)

595/4360 (13.6)

183/3244 (5.6)

Amiodarone‡‡

428/4336 (9.9)

377/4360 (8.6)

249/3244 (7.7)

n engl j med 365;9
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Table 2. (Continued.)
Characteristic

Sham ITD (N = 4345)

Active ITD (N = 4373)

Not Enrolled (N = 3613)

Later-analysis group

1860 (42.8)

1815 (41.5)

1368 (37.9)

Early-analysis group

1634 (37.6)

1632 (37.3)

1128 (31.2)

851 (19.6)

926 (21.2)

1117 (30.9)

Coenrollment in companion study — no. of patients (%)

Not enrolled in companion study
Hospital procedures — no. of patients/total no. (%)§§
Hypothermia

554/1147 (48.3)

543/1142 (47.5)

292/906 (32.2)

Coronary catheterization

358/1147 (31.2)

324/1142 (28.4)

312/906 (34.4)

Implantable cardioverter–defibrillator

110/1147 (9.6)

105/1142 (9.2)

71/906 (7.8)

*		 Plus–minus values are means ±SD. The P values for all comparisons were not significant (≥0.05) unless otherwise noted. AED denotes
automated external defibrillator, ITD impedance threshold device, VF ventricular fibrillation, and VT ventricular tachycardia.
†		 The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 1788, 1731, and 1156, respectively.
‡		 The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 1227, 1220, and 503, respectively.
§		 The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 1250, 1235, and 539, respectively.
¶		 The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 2786, 2739, and 1370, respectively.
‖		 The total numbers of patients in the sham-ITD, active-ITD, and not-enrolled groups were 1888, 1862, and 924, respectively.
** The CPR fraction is the percentage of time that compressions were given during resuscitation. The total numbers of patients in the
sham-ITD, active-ITD, and not-enrolled groups were 2791, 2743, and 1372, respectively.
†† The mean doses of epinephrine were 3.7±1.9 (in 3789 patients), 3.7±2.0 (in 3851), and 3.3±2.0 (in 2036) for the sham-ITD, active-ITD,
and not-enrolled groups, respectively.
‡‡ The difference between the sham-ITD group and the active-ITD group was significant (P<0.05).
§§ A total of 1149 patients in the sham-ITD group, 1143 in the active-ITD group, and 909 in the not-enrolled group were admitted to the
hospital. Data regarding procedures were available for 1147, 1142, and 906 patients, respectively.

dence interval, −1.1 to 0.8; P = 0.71) (Table 3). There
were also no significant between-group differences in the primary outcome with the analysis
adjusted for baseline characteristics, in any of the
secondary outcomes, or in adverse events as assessed in the safety population.
Subgroup Analyses

There were no significant differences in a priori
subgroup analyses between the sham-ITD and active-ITD groups (Fig. 3 in the Supplementary Appendix). Post hoc, exploratory subgroup analyses
showed that for subgroups defined by the CPR
fraction (the percentage of time that compressions
were delivered during resuscitation), patients in the
second-lowest quartile (59.9 to 71.0%) who were
treated with an active ITD had significant improvement in survival to hospital discharge with
satisfactory functional status (P<0.01; P = 0.006
for interaction). There were no significant differences between use of the sham ITD and use of
the active ITD in any other exploratory subgroup
analysis (Fig. 3 in the Supplementary Appendix).
Variation in treatment effect from site to site
was consistent with random variation. The chisquare test for heterogeneity was not significant (P = 0.4).

n engl j med 365;9

Discussion
Physiological studies in animals and humans have
suggested that interventions capable of decreasing mean intrathoracic pressure can augment the
return of venous blood to the heart and improve
hemodynamics during CPR.3-5,7 Despite such findings, this large effectiveness trial did not confirm
a survival advantage with the use of an active ITD
during standard CPR in patients with nontraumatic, out-of-hospital cardiac arrest.
One possible explanation for the neutral results is that, despite the evidence cited, the ITD
may not generate the physiological effects that
have been proposed. Two studies in animals that
were published after the present trial began enrollment showed no improvement in hemodynamics
or survival with application of the ITD during
standard CPR.17,18
A second possible explanation is that use of the
active ITD by the participating EMS systems did
not recreate the physiological effects seen in some
of the experimental studies.3-5,7 Delayed application of the ITD, failure to prevent airway leaks, and
suboptimal performance of CPR can interfere with
the hemodynamic improvements that are associated with ITD use.19-22 For these reasons, the ROC
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Table 3. Outcomes in the Modified Intention-to-Treat (ITT) and Safety Populations.*
Sham ITD
(N = 4345)

Active ITD
(N = 4373)

Percentage-Point
Difference (95% CI)

P Value

Transported to hospital — no. of patients (%)

2451 (56.4)

2448 (56.0)

−0.4 (−2.5 to 1.7)

0.69

ROSC on arrival at emergency department — no. of
patients (%)

1206 (27.8)

1186 (27.1)

−0.6 (−2.5 to 1.2)

0.51

Survival to hospital admission — no. of patients (%)

1139/4335 (26.3)

1140/4370 (26.1)

−0.2 (−2.0 to 1.7)

0.84

355 (8.2)

357 (8.2)

0.0 (−1.2 to 1.1)

0.99

−0.1 (−1.1 to 0.8)

0.71

Outcome
Modified ITT population

Survival to discharge — no. of patients (%)
Score on modified Rankin scale — no. of patients (%)†
≤3‡

260 (6.0)

254 (5.8)

0

73 (1.7)

81 (1.9)

1

87 (2.0)

77 (1.8)

2

28 (0.6)

22 (0.5)

3

72 (1.7)

74 (1.7)

4

57 (1.3)

55 (1.3)

5

38 (0.9)

48 (1.1)

6

3990 (91.8)

4016 (91.8)

5.69±1.15

5.69±1.14

0.01 (−0.04 to 0.05)

0.83

140/5790 (2.4)

144/5802 (2.5)

0.1 (−0.5 to 0.6)

0.61

Mean modified Rankin score
Safety population§
ITD not removed after ROSC — no. of patients/total no. (%)
Suspected device failure — no. of patients/total no. (%)

4/5790 (0.1)

9/5802 (0.2)

0.1 (0.0 to 0.2)

0.17

Pulmonary edema — no. of patients/total no. (%)

346/5790 (6.0)

336/5802 (5.8)

−0.2 (−1.0 to 0.7)

0.67

Airway bleeding — no. of patients/total no. (%)

176/5790 (3.0)

179/5802 (3.1)

0.0 (−0.6 to 0.7)

0.89

* Plus–minus values are means ±SD. ITD denotes impedance threshold device, and ROSC return of spontaneous circulation.
† The modified Rankin scale ranges from 0 to 6, with higher numbers indicating greater disability.
‡ The risk differences, confidence intervals, and P values were adjusted for sequential monitoring.
§ The total numbers for the sham-ITD and active-ITD groups are higher (5790 and 5802, respectively) because they include the safety population in both the run-in phase (1107 patients in the sham-ITD group and 1115 patients in the active-ITD group) and the main trial (4683 patients in the sham-ITD group and 4687 patients in the active-ITD group).

investigators implemented comprehensive training, retraining, electronic monitoring of the CPR
process, and follow-up quality-assurance monitoring. The quality of the CPR provided was associated with outcomes in the sham-ITD group that
were better than expected. Therefore, it is not
likely that EMS systems would apply the ITD in a
more operationally efficacious way than they were
applied in this study.
Another possible explanation is that application of the active ITD produced the physiological
effects seen in experimental studies but did not
improve clinical outcomes. It is possible that failure to remove the ITD immediately after successful resuscitation, with the resulting increased work
of breathing, increases interstitial lung fluid and
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left-sided pressures and worsens heart failure, or
that such failure increases venous pressure, decreasing cerebral perfusion pressure in the resuscitated state. Other interventions (e.g., the administration of epinephrine) might exacerbate these
potential complications.
Several limitations of the trial should be noted.
The investigators did not directly measure hemodynamics, intrathoracic pressure, ventilation rate
and duration, or the effects of ITD use during
gasping and spontaneous ventilation. CPR process
measures were not recorded in all cases. Although
use of the modified Rankin scale has been validated for assessing the effects of stroke, it lacks
validation for cardiac arrest. In only 61.5% of
patients who received the active ITD was it placed
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within 5 minutes after the arrival of EMS per- in patients with nontraumatic, out-of-hospital carsonnel.
diac arrest. Use of the active ITD did not signifiAnother factor of potential importance that cantly improve survival with satisfactory function.
was not measured in this study is chest recoil.22
Supported by a series of cooperative agreements with 10 reLoss of elastic recoil of the chest can occur over gional clinical centers and one data coordinating center (5U01
time during standard CPR.23 Since the purpose HL077863, HL077881, HL077871, HL077872, HL077866,
HL077908, HL077867, HL077887, HL077873, HL077865) from the
of the ITD is to enhance negative intrathoracic National Heart, Lung, and Blood Institute in partnership with
pressure by preventing passive air inflow during the National Institute of Neurological Disorders and Stroke,
chest recoil, loss of such recoil is a potential U.S. Army Medical Research and Materiel Command, the Institute of Circulatory and Respiratory Health of the Canadian Instilimitation in achieving the desired physiological tutes of Health Research, Defence Research and Development
result. A recent study showed that combining the Canada, the Heart and Stroke Foundation of Canada, and the
use of an ITD and active compression–decompres- American Heart Association.
Disclosure forms provided by the authors are available with
sion CPR significantly increases survival to hospi- the full text of this article at NEJM.org.
tal discharge with satisfactory function, as comWe thank the thousands of EMS providers and first responders who made this logistically challenging trial possible (perpared with standard CPR.24
sonnel from all participating sites are listed in the SupplemenIn conclusion, we compared use of an active tary Appendix); and Alfred P. Hallstrom, Ph.D., Scott S. Emerson,
ITD with use of a sham ITD during standard CPR M.D., Ph.D., and Gerald van Belle, Ph.D., for their leadership.
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(G.N., S.P.B., B.G.L., L.V.O.) — all at the University of Washington, Seattle; the Department of Surgery (Emergency Medicine),
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